Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-08

Clinical Trial Update: Nuvigil in Treatment of Cancer-Related Fatigue in Chronic Myeloid Leukemia Patients [NA]

View source ↗

Summary

A terminated MD Anderson clinical trial evaluated armodafinil (Nuvigil) for cancer-related fatigue in chronic myeloid leukemia patients, with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NUVIGIL (armodafinil)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Chronic Myeloid Leukemia | NA | Status: TERMINATED | Results posted: 2015-12-08